JACQUELYN BAKER: Open Payments
NPI 1144713728 · BRISTOL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,458 in 79 payments from 14 companies in 2025. Trend: 2023 $1,209 · 2024 $1,356 · 2025 $1,458
Food & beverage: $1,359Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $364 |
| ABBVIE INC. | 15 | $168 |
| Ardelyx, Inc. | 8 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $133 |
| Celltrion USA Inc. | 5 | $98 |
| Gilead Sciences, Inc. | 4 | $93 |
| QOL Medical, LLC | 4 | $92 |
| Aimmune Therapeutics, Inc. | 5 | $87 |
| Ferring Pharmaceuticals Inc. | 3 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
Products named: TREMFYA, IBSRELA, VEGZELMA, Sucraid, ENTYVIO, ZENPEP, REBYOTA, RINVOQ.
Industry payments across TN — which companies pay providers there.
